GB0211500D0 - Method of forming iron hydroxypyrone compounds - Google Patents

Method of forming iron hydroxypyrone compounds

Info

Publication number
GB0211500D0
GB0211500D0 GBGB0211500.4A GB0211500A GB0211500D0 GB 0211500 D0 GB0211500 D0 GB 0211500D0 GB 0211500 A GB0211500 A GB 0211500A GB 0211500 D0 GB0211500 D0 GB 0211500D0
Authority
GB
United Kingdom
Prior art keywords
forming iron
iron hydroxypyrone
hydroxypyrone compounds
compounds
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0211500.4A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitra Pharmaceuticals Ltd
Original Assignee
Vitra Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitra Pharmaceuticals Ltd filed Critical Vitra Pharmaceuticals Ltd
Priority to GBGB0211500.4A priority Critical patent/GB0211500D0/en
Publication of GB0211500D0 publication Critical patent/GB0211500D0/en
Priority to ES03727643T priority patent/ES2283771T3/es
Priority to US10/514,836 priority patent/US7459569B2/en
Priority to EP03727643A priority patent/EP1506183B1/en
Priority to AT03727643T priority patent/ATE352547T1/de
Priority to PCT/GB2003/001956 priority patent/WO2003097627A1/en
Priority to DE60311456T priority patent/DE60311456T2/de
Priority to CA2483067A priority patent/CA2483067C/en
Priority to AU2003233881A priority patent/AU2003233881A1/en
Priority to FR16C0033C priority patent/FR16C0033I2/fr
Priority to BE2016C041C priority patent/BE2016C041I2/nl
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compounds Of Iron (AREA)
  • Plural Heterocyclic Compounds (AREA)
GBGB0211500.4A 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds Ceased GB0211500D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB0211500.4A GB0211500D0 (en) 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds
AU2003233881A AU2003233881A1 (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds
AT03727643T ATE352547T1 (de) 2002-05-18 2003-05-07 Verfahren zur herstellung von eisenhydroxypyronverbindungen
US10/514,836 US7459569B2 (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds
EP03727643A EP1506183B1 (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds
ES03727643T ES2283771T3 (es) 2002-05-18 2003-05-07 Metodos para la formacion de compuestos de hidroc[xipirona de hierro.
PCT/GB2003/001956 WO2003097627A1 (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds
DE60311456T DE60311456T2 (de) 2002-05-18 2003-05-07 Verfahren zur herstellung von eisenhydroxypyronverbindungen
CA2483067A CA2483067C (en) 2002-05-18 2003-05-07 Method of forming iron hydroxypyrone compounds
FR16C0033C FR16C0033I2 (fr) 2002-05-18 2016-08-09 Methode de formation de composes d'hydroxypyrone de fer
BE2016C041C BE2016C041I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2002-05-18 2016-08-17

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0211500.4A GB0211500D0 (en) 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds

Publications (1)

Publication Number Publication Date
GB0211500D0 true GB0211500D0 (en) 2002-06-26

Family

ID=9936987

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0211500.4A Ceased GB0211500D0 (en) 2002-05-18 2002-05-18 Method of forming iron hydroxypyrone compounds

Country Status (11)

Country Link
US (1) US7459569B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP1506183B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE352547T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU2003233881A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE2016C041I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA2483067C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE60311456T2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2283771T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR16C0033I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB0211500D0 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
WO (1) WO2003097627A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8952061B2 (en) * 2006-08-22 2015-02-10 University Of Virginia Patent Foundation Methods and compounds regulating the erythroid response to iron deficiency
JP5756598B2 (ja) 2007-02-06 2015-07-29 メディカル リサーチ カウンシル リガンド修飾ポリオキソヒドロキシ金属イオン物質、それらの使用およびそれらの調製方法
GB0808835D0 (en) 2008-05-15 2008-06-18 Vitra Pharmaceuticals Ltd Therapeutic compositions
US8536106B2 (en) 2010-04-14 2013-09-17 Ecolab Usa Inc. Ferric hydroxycarboxylate as a builder
GB201101370D0 (en) 2011-01-27 2011-03-09 Iron Therapeutics Holdings Ag Process
GB201404390D0 (en) * 2014-03-12 2014-04-23 Iron Therapeutics Holdings Ag Composition
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
GB2531742B (en) 2014-10-28 2016-10-05 Iron Therapeutics Holdings Ag Polymorphs of ferric maltol
GB201517893D0 (en) 2015-10-09 2015-11-25 Medical Res Council Methods for producing carboxylate ligand modified ferric iron hydroxide colloids
AU2017242905B2 (en) * 2016-03-31 2020-10-22 Shield TX (UK) Limited Methods for producing ferric maltol compositions from elemental iron
EP3436442B1 (en) * 2016-03-31 2020-10-28 Shield TX (UK) Limited Methods for producing ferric maltol compositions from ferrous hydroxides
CN109310667B (zh) 2016-03-31 2022-01-11 英国神盾Tx股份有限公司 用于治疗或预防癌症和肿瘤的麦芽酚铁组合物
CN109790138B (zh) * 2016-03-31 2023-08-18 英国神盾Tx股份有限公司 由配体修饰的和配体涂覆的氢氧化铁生产麦芽酚铁组合物的方法
GB202005054D0 (en) 2020-04-06 2020-05-20 Nemysis Ltd Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases
CN112574158B (zh) * 2020-12-29 2022-08-02 南京百泽医药科技有限公司 一种麦芽酚铁晶型ii及其制备方法
CN115177625A (zh) * 2022-06-28 2022-10-14 金陵药业股份有限公司 一种羧基麦芽糖铁药用组合物及其制备方法

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3130204A (en) 1962-02-07 1964-04-21 Pfizer & Co C Preparation of gamma-pyrones
DE1518098A1 (de) 1963-09-19 1969-04-10 Pfizer & Co C Verfahren zur Herstellung von Pyromekonsaeurederivaten
SE322866B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1966-12-15 1970-04-20 Astra Ab
US4018907A (en) 1975-08-25 1977-04-19 General Foods Corporation Coloring food with iron-complexes
US4212685A (en) * 1978-12-11 1980-07-15 Lea Manufacturing Company Protective and color receptive coating for aluminum
US4279936A (en) 1979-09-24 1981-07-21 William Underwood Company Maltol treated canned meat process
US4550101A (en) 1982-03-24 1985-10-29 National Research Development Corporation Iron complexes of hydroxy pyridones useful for treating iron deficiency anemia
GR78491B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1982-03-24 1984-09-27 Nat Res Dev
EP0107458B1 (en) 1982-10-22 1987-07-29 National Research Development Corporation Pharmaceutical compositions
GB8308055D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8308054D0 (en) 1983-03-24 1983-05-05 Hider R C Pharmaceutical compositions
GB8325494D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
USRE34313E (en) 1983-09-23 1993-07-13 National Research Development Corporation Pharmaceutical compositions
GB8325496D0 (en) 1983-09-23 1983-10-26 Hider R C Pharmaceutical compositions
US4912118A (en) 1983-09-23 1990-03-27 National Research Development Corporation Pharmaceutical compositions
GB8329043D0 (en) 1983-10-31 1983-11-30 Hider R C Pharmaceutical compositions
GB8410290D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
US5177068A (en) 1984-04-19 1993-01-05 National Research Development Corporation Pharmaceutical compositions
GB8410289D0 (en) 1984-04-19 1984-05-31 Callingham B A Pharmaceutical compositions
GB8606913D0 (en) 1986-03-20 1986-04-23 Hider R C Treatment of sickle cell disease
JPH0367565A (ja) 1989-08-07 1991-03-22 Kansai Paint Co Ltd 鉄分強化食品
GB9209078D0 (en) 1992-04-27 1992-06-10 Hider Robert C Pharmaceutical compositions
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
EP0833627B1 (en) 1995-06-10 2004-08-18 Vitra Pharmaceuticals Ltd. Iron compounds, compositions, methods of making the same and uses thereof
GB9621273D0 (en) 1996-10-11 1996-11-27 Cortecs Ltd Therapeutic method

Also Published As

Publication number Publication date
EP1506183A1 (en) 2005-02-16
CA2483067A1 (en) 2003-11-27
DE60311456T2 (de) 2007-11-15
FR16C0033I1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2016-09-23
US7459569B2 (en) 2008-12-02
ATE352547T1 (de) 2007-02-15
DE60311456D1 (de) 2007-03-15
ES2283771T3 (es) 2007-11-01
US20050250754A1 (en) 2005-11-10
BE2016C041I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2022-08-09
CA2483067C (en) 2011-04-26
FR16C0033I2 (fr) 2018-01-19
AU2003233881A1 (en) 2003-12-02
WO2003097627A1 (en) 2003-11-27
EP1506183B1 (en) 2007-01-24

Similar Documents

Publication Publication Date Title
BE2016C041I2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP2272825A3 (en) N-Protected amino hydroxy adamantane carboxylic acid and process for its preparation
MXPA03009565A (es) Derivado de acido carboxilico y una sal del mismo.
ATE330328T1 (de) Neue zusammensetzung zum selektiven ätzen von oxiden auf metallen
MXPA01002392A (es) Metodos y composiciones acidificadas para reducir la corrosion en las superficies de metal y la precipitacion del sulfuro.
CA2457584A1 (en) Enhancing solubility of iron amino acid chelates and iron proteinates
CA2373834A1 (en) A process for the production of thiazolidine
WO2002076378A3 (es) Proceso para producir un hidróxido cúprico estable y sales cúpricas básicas
CA2455539A1 (en) Pig growth enhancer and pig growth enhancing method
CY1108593T1 (el) Συμπυκνωμενο υδατικο διαλυμα αμβροξολης
WO2003088956A8 (en) Method for treating ileus with an alpha -ketoalkanoic acid or - ester or - amide
WO2003062344A3 (en) Acidizing and scale treatment of subterranean formation
MY134966A (en) Alkaline earth metal complexes and their use
MXPA03007455A (es) Metodo y produccion de acido d-pantotenico y las sales de este como adyuvante en productos alimenticios para animales.
PL365213A1 (en) Enteric ketoacid salts and amino acids
WO2004095921A3 (en) Sporicidal composition
SI1620423T1 (sl) Postopek za pripravo (4-hidroksi-6-okso-tetrahidro-piran-2-il)-aceetonitrila in njihovih derivatov
IL157402A0 (en) Method for producing d-pantothenic acid and/or salts therefor as an additive for animal feed
IN2003CH01298A (en) Method for producing D-pantothenic acid and/or salt thereof as additive for animal feesdstuffs
IL157496A0 (en) Method for producing d-pantothenic acid and/or salts thereof as additive to animal feed
HRP20031004A2 (en) Method for producing an essentially chlorite-free,stable, aqueous chlorine-oxygen solution, the chlorine-oxygen solution obtained by means of said method, and the use of the same
AU2002250978A1 (en) Method for producing D-pantothenic acid and/or salts thereof as an additive for animal feed
MY134147A (en) Method for stoping hysteresis
RU2000109795A (ru) Способ получения магнитоактивного соединения
MXPA04000513A (es) Proceso para la preparacion de 4-metilamino-4-fenilpiperidina.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)